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Abstract Assessment options are extremely limited for
the evaluation of treatment outcome in a specific phobia of
vomiting (emetophobia). We aimed to assist researchers
and clinicians in the measurement of cognitive processes
and behaviors that are characteristic of the disorder for
treatment planning and outcome measurement. We devel-
oped the specific phobia of vomiting inventory (SPOVI). A
series of measures, including the SPOVI, were given to two
groups: a group diagnosed with a specific phobia of vom-
iting and a community control group. Item characteristics,
reliability, and factor structure were analysed. Convergent
validity with measures of related constructs was deter-
mined. The SPOVI was found to have good reliability and
validity in the measurement of a phobia of vomiting. The
scale has a two-factor structure, with one factor charac-
terised by avoidance symptoms and a second factor com-
prised of threat monitoring. It is sensitive to change during
treatment. The results provide initial evidence of the
psychometric qualities of the SPOVI and its suitability for
use in clinical practice and research.
Keywords Specific phobia  Vomiting  Inventory 
Questionnaire, emetophobia
Introduction
A Specific Phobia of Vomiting or emetophobia is a clinical
condition characterised by a preoccupation with and fear of
vomiting. Emetophobia is a neglected area of research. The
condition appears uncommon, with a prevalence of 0.1 %
in the only epidemiological survey that has specifically
asked about a phobia of vomiting (Becker et al. 2007).
Previous estimates of prevalence may, however, be
underestimates as the symptoms may be confused with
symptoms of health anxiety, obsessive–compulsive disor-
der, social phobia, panic disorder, and anorexia nervosa
(Boschen 2007; Veale 2009). Thus some people with
SPOV may have checking compulsions (for example
excessive checking that food is not out of date or that
others are not ill in order to reduce the risk of vomiting).
However an additional diagnosis of co-morbid obsessive—
compulsive disorder would only be used when the obses-
sions are not restricted to fears of vomiting. This is the
same for health anxiety in which people with SPOV may
worry and seek reassurance about themselves or others not
vomiting. However a diagnosis of health anxiety is only
made if the fears of being ill are not confined to vomiting.
Symptoms of nausea and misinterpretation as evidence of
vomiting might also arise, for example, in panic disorder
and agoraphobia, but these are invariably associated with
other symptoms of panic (e.g. palpitations for heart attack,
shortness of breath for stopping breathing). Similar issues
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exist for specific phobias linked to other bodily functions
such as choking or incontinence. At the symptom level,
anxiety about vomiting has been reported in as many as
3.1 % of males and 7 % of females (Kirkpatrick and Berg
1981, cited in Philips 1985).
Despite being uncommon compared to specific phobias in
general, emetophobia can lead to significant impairment, and
reduced quality of life. Female-specific impairments include
avoiding a desired pregnancy out of fear of morning sickness
and the propensity of babies to vomit also causes problems
(Veale and Lambrou 2006). Individuals with emetophobia
usually report early onset of the condition, with a chronic
course lasting over many years, and very few periods of
remission (Lipsitz et al. 2001). Individuals with emetophobia
also report significant distress due to their symptoms (Lipsitz
et al. 2001). Fear and avoidance associated with emetopho-
bia impairs functioning in a range of ways, such as being
significantly underweight from dietary restriction and mis-
diagnosis of anorexia nervosa (Veale et al. 2012), avoiding
social or public situations where there may be a perceived
risk of vomiting. There are frequent safety-seeking behav-
iors which may be either overt or a covert mental act with the
aim of preventing oneself or others from being sick. Overt
behaviors include checking of ‘sell by’ dates and freshness of
food, reassurance seeking, excessive cooking of food,
excessive washing of hands or cleaning with anti-bacterial
sprays, or drinking bottled water to check no food is coming
up. Covert acts include a person mentally reviewing her or
others’ actions and reassuring herself that she will not vomit.
There is some evidence for associative learning in emeto-
phobia whereby aversive consequences of vomiting become
associated with an unrelated life event (Veale et al. 2012). It
suggests a model of autobiographical memories of vomiting
that have lost a time perspective and context becoming reac-
tivated by cues of vomiting. There is also a gender bias
towards women in emetophobia. This does not necessarily
indicate for a higher genetic contribution to a disorder unless a
rare mechanism like an X-chromosome linked disorder or a
mitochondrial DNA transmission is hypothesized. The higher
prevalence in women may be a reflection of an increased
disgust sensitivity and preparedness as a result of a greater
responsibility for the care of children.
Treatment outcome studies for emetophobia are limited to
clinical case reports although earlier studies often do not
describe the diagnostic criteria that were used or give detail
on the outcome. Procedures used include video-taped
exposure to others vomiting (Philips 1985); graded exposure
to simulated vomiting (McFadyen and Wyness 1983);
exposure (‘‘flooding’’) to vomiting under hypnosis (Wije-
singhe 1974); exposure to nausea (Lesage and Lamontagne
2003); exposure to interceptive cues of vomiting (Hunter
and Antony 2009); systemic behavior therapy (O’Connor
1983); competence imagery (Moran and O’Brien 2005);
psychodynamic therapy and exposure (Ritow 1979); hyp-
notherapy (McKenzie 1994); psychotherapy (Manassis and
Kalman 1990). None of these treatment outcome studies of
emetophobia have used a standardized, psychometrically
validated measure of emetophobic related symptoms or of a
specific phobia (Antony 2001). They have utilized a diverse
array of outcome measures such as anxiety ratings to vom-
iting cues or simulated vomiting (McFadyen and Wyness
1983; Philips 1985), diary records of episodes of nausea
(Lesage and Lemontagne 2003) or non-specific measures of
anxiety (Moran and O’Brien 2005; Hunter and Antony
2009). Several have not used any outcome measures at all
(Wijesinghe 1974; O’Connor 1983; Manassis and Kalman
1990; McKenzie 1994; Ritow 1979). The lack of a specific
measure of emetophobia makes comparison between out-
comes of different therapies very difficult (Jacobsen et al.
1999). The use of different measures also prevents aggre-
gation of results from the small number of existing studies for
use in statistical procedures such as meta-analysis. More
general anxiety measures or inventories may allow for the
calculation of the effect size of treatments on these general
symptoms, but do not allow for evaluation of the specific
effect of treatment on emetophobia symptoms.
The present study addresses the lack of established
measures of emetophobia by validating a self-report
inventory, the specific phobia of vomiting inventory
(SPOVI). The SPOVI is a self-report measure that focuses
on the cognitive processes and avoidance behaviors that are
characteristic of the disorder. We desired a scale that was
free, brief and suitable for the assessment of symptom
change during treatment. Furthermore, we sought to create
a scale that would assist clinicians in identifying the most
frequent cognitive processes and behaviors that theoreti-
cally maintain the symptoms, and which therefore could be
targeted in therapy.
Method
Participants
Participants of both sexes were recruited for the clinical
sample; for the control group, recruitment was matched for
gender to balance the significant over-representation of
females in the clinical cohort.
Emetophobia Group
The emetophobia group consisted of 95 participants with
DSM-IV diagnosis of a specific phobia of vomiting as their
main problem (89 females, 6 males), 25 of whom were
recruited from a clinical setting, and a further 70 from the
Internet. The clinical participants were from an out-patient
596 Cogn Ther Res (2013) 37:595–604
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setting and had either had an assessment at our service or
were waiting for treatment either at our service or else-
where. The non-clinical participants were recruited from an
advertisement on three Internet support groups for emeto-
phobia (Gut Reaction, International Emetophobia Society
and Anxiety UK; n = 70).
Of those participants in the emetophobia cohort, 60
(63.2 %) reported no comorbid diagnoses, 20 (21.1 %) had
one comorbid diagnosis and 15 (15.8 %) had two or more
comorbid diagnoses. The most common comorbidities
among the participants were depression (n = 8, 8.4 %),
GAD (n = 8, 8.4 %), OCD (n = 6, 6.3 %), somatisation
(n = 5, 5.3 %), panic disorder (n = 4, 4.2 %), social
phobia (n = 4, 4.2 %), agoraphobia (n = 2, 2.2 %), health
anxiety (n = 1, 1.1 %), and other specific phobia (n = 1,
1.1 %).
Community Group
A community sample was obtained for the purpose of
comparison with our clinical cohort on the new measure.
A community group (N = 90) was identified on the
Mind Search database at the Institute of Psychiatry,
Kings College London. This database contains details for
over 3,500 individuals in the local community who have
volunteered to participate in psychological or psychiatric
research.
Participants were excluded from both groups if they
were at greater risk of vomiting. This was to ensure that the
control group were likely to have a similar frequency of
vomiting as the emetophobia group. The exclusion criteria
were: an eating disorder with self-induced vomiting; sui-
cidal intent and a history of taking an overdose that could
induce vomiting; regular binge drinking and vomiting; use
of illegal substances that might cause vomiting (e.g., opi-
ates); current use of medication or other treatments that can
cause vomiting (e.g., chemotherapy; radiotherapy); current
medical problems that could cause vomiting (e.g., peptic
ulcer, cancer, migraine); or current pregnancy.
There were no significant differences in age (t = 0.08,
df = 182, p = .94) or gender distribution (v2 = 2.53,
df = 1, p = .11) between the emetophobia or community
control groups. Demographic details of both samples are
presented in Table 1.
Procedure
The diagnosis of a specific phobia of vomiting was made
using the Structured Clinical Interview for DSM Disorders
(SCID) for DSM-IV (APA 1994). The Psychiatric Diag-
nostic Screening Questionnaire (PDSQ; Zimmerman and
Mattia 2001) was used to identify possible alternative
diagnoses and co-morbid conditions before using the
SCID. A clinical research worker trained in the use of the
SCID interviewed participants recruited via the Internet
over the telephone. The diagnosis of a specific phobia of
vomiting in patients recruited within the clinical setting
was determined in the context of a clinical assessment by a
psychologist or psychiatrist using the SCID. After they
consented, they completed all the study questionnaires.
All the participants with emetophobia recruited from the
Internet were invited to be retested but only 31 agreed and
provided retest data. Those retested were not significantly
different on the SPOVI to those who were not retested
(t = 0.31, p = .76). The retesting was administered online.
The test–retest reliability was not conducted in the com-
munity group.
Eight participants from the emetophobia group were fol-
lowed up during treatment. They were chosen because they
had funding and were able to have treatment in our setting.
Therapists followed a treatment protocol described by Veale
(2009) that included a formulation and procedures that
included (a) imagery re-scripting to past experiences of
vomiting, (b) exposure to situations and activities associated
with vomiting (Wolitzky-Taylor et al. 2008), (c) modifying
safety seeking behaviors and cognitive processes such as
reducing self-focussed attention, checking and worrying.
They attended weekly therapy for up to 12 one-hour sessions.
These participants completed the SPOVI, PHQ9, and GAD7
at pre-treatment, mid-treatment and at the end of therapy.
All participants received a gift voucher of £10 after
completion of the questionnaires. SelectSurveyASP (TM)
Table 1 Demographic details of the clinical and community samples
Emetophobic
(N = 95)
Community
(N = 90)
Age M = 32.61,
SD = 12.09
M = 32.47,
SD = 11.00
Sex
Male 6 (6.3 %) 3 (3.3 %)
Female 89 (93.7 %) 87 (96.7 %)
Marital status
Single 37 (38.9 %) 47 (52.2 %)
Married/cohabiting 53 (55.8 %) 37 (41.1 %)
Divorced 4 (4.2 %) 2 (2.2 %)
Not recorded 1 (1.1 %) 4 (4.4 %)
Employment status
Unemployed 5 (5.3 %) 5 (5.6 %)
Long-term sick leave 4 (4.2 %) 1 (1.1 %)
Student 15 (15.8 %) 21 (23.3 %)
Employed 55 (57.9 %) 55 (61.1 %)
Homemaker 7 (7.4 %) 5 (5.6 %)
Other 7 (7.4 %) 2 (2.2 %)
Not recorded 2 (2.1 %) 1 (1.1 %)
Cogn Ther Res (2013) 37:595–604 597
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version 8.1.1 was used to create a web-based version of the
questionnaires completed for the control group and par-
ticipants in the emetophobia group who were recruited over
the Internet. The format and structure of the questions were
identical to the paper version used in the clinical setting.
Materials
The following questionnaires were completed by each
participant in the emetophobia and community control
group, in addition to the gathering of basic demographic
data.
Specific Phobia of Vomiting Inventory (SPOVI)
The SPOVI consists of 14 items each scored on a Likert-
type scale for frequency from 0 (not at all) to 4 (all the
time). The items refer to the past week. The total score
ranges from 0 to 56 with a higher score reflecting greater
frequency of emetophobia-related symptoms.
Items for the SPOVI were generated from interviews in
a previous study on the psychopathology of a specific
phobia of vomiting in which we identified the characteristic
cognitive processes and behaviors (Veale and Lambrou
2006; Price et al. 2012). Items followed a theoretical model
for the maintenance of symptoms of a specific phobia of
vomiting (Veale 2009). We also drew upon established
trans-diagnostic processes that occur in anxiety disorders
(Harvey et al. 2004). A process of iteration occurred so that
experienced clinicians and patients with emetophobia
reviewed the wording of the draft version. Where the
meaning or context of an item was unclear, it was
accordingly modified. It was pilot tested in people with
specific phobia of vomiting before the final version was
used for the study.
Disgust Scale Revised (DS-R; Olatunji et al. 2007)
The DS-R is a self-report questionnaire originally devel-
oped by Haidt et al. (1994) as a general tool for the study of
disgust. It has been previously used to measure individual
differences in sensitivity to disgust, and to examine the
relations among different kinds of disgust. Van Overveld
et al. (2008) have previously reported that people with
emetophobia have increased levels of disgust propensity
and sensitivity. The DS-R is a shortened version of the
original Disgust Scale, with the number of items reduced
from 32 to 25, and the number of subscales reduced from
eight to three (core disgust, animal-reminder disgust, and
contamination disgust). The response format for items is a
5-point Likert scale from 0 (not disgusting at all/strongly
disagree) to 4 (extremely disgusting/strongly agree). The
total score is in the possible range of 0–100. Cronbach’s
alpha in the current sample was .87.
Obsessive Compulsive Inventory (OCI; Foa et al. 1998)
The OCI is a 42-item self-report measure of obsessive–
compulsive disorder symptoms. In the current study,
participants rated each item for distress on a 5-point
Likert scale from 0 (not at all) to 4 (extremely), yielding
a possible range of 0–168. Distress can also be rated
separately for each of seven subscales: Washing,
Checking, Doubting, Ordering, Obsessing, Hoarding, and
Neutralizing but these were not utilized because of the
risk of generating false positive associations from more
statistical analyses. The Cronbach’s alpha of the OCI in
the current sample was .96.
Health Anxiety Inventory (HAI; Salkovskis et al. 2002)
The HAI is a self-rated measure of health anxiety that is
sensitive across the full range of intensity (from mild
concern to frank hypochondriasis). The HAI differentiates
people suffering from health anxiety from those who have
actual physical illness, but who are not excessively con-
cerned about their health. It also encompasses the full
range of clinical symptoms characteristic of clinical
hypochondriasis. We used the short version (14 items) of
the scale. The possible range for the total is 0–42. The
Cronbach’s alpha in the current sample was .95.
Emetophobia Questionnaire (EmetQ-13)
(Reddell 2006). The EmetQ-13 is a 13-item scale that is
answered on a Likert-scale from 1 (‘strongly disagree’) to 5
(‘strongly agree’) with a possible range of 13–65. The
EmetQ-13 has a clear three-factor structure. It has good
internal consistency (a = .82 in the clinical sample, and
a = .85 in a control sample), and one-week test–retest
reliability (r = .76). The EmetQ-13 also shows excellent
ability to differentiate individuals with emetophobia from
non-clinical controls. The questionnaire focuses on avoid-
ance of vomit-related situations (e.g., ‘I avoid places where
others may vomit’) and beliefs about nausea (e.g. If I see
vomit, I may be sick myself’). The EmetQ-13 and the
SPOVI were developed independently in Australia and the
United Kingdom, respectively.
PHQ-9 Depression Severity (Kroenke and Spitzer 2002)
The Patient Health Questionnaire (PHQ) is a self-report
version of the PRIME-MD diagnostic instrument for
common mental disorders. The PHQ-9 is the depression
module, which scores each of the 9 DSM-IV criteria as ‘‘0’’
598 Cogn Ther Res (2013) 37:595–604
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(not at all) to ‘‘3’’ (nearly every day). The PHQ-9 total
score for the 9 items ranges from 0 to 27. The PHQ-9
demonstrated high internal consistency in the current
sample (Cronbach’s a = .93).
Generalized Anxiety Disorder assessment (GAD-7; Spitzer
et al. 2006)
The GAD-7 is designed primarily as a screening and
severity measure for symptoms of generalized anxiety
disorder. The scale is scored from ‘‘0’’ (not at all) to ‘‘3’’
(nearly every day) and the total score for the 7 items ranges
from 0 to 21. The internal consistency of the GAD-7 on the
current study was high (Cronbach’s a = .94).
Work and Social Adjustment Scale (WSAS; Mundt et al.
2002)
Emetophobia participants completed the WSAS, which
was adapted to focus on the fear of vomiting. This scale
measures impairment in functioning, and has five items:
‘‘To what extent does your fear of vomiting currently have
an effect on your (a) ability to work or study; (b) home
management; (c) social life; (d) leisure activities; and
(e) relationship with a partner’’. Items are scored between 0
(‘‘Not at all’’) and 8 (‘‘Extremely’’), and the possible range
for the total score across the five items was 0 to 40.
Cronbach’s alpha in our sample was .69.
Results
Prior to analysis, data were examined to ensure suitability
for statistical analysis. All assumptions were satisfied
unless otherwise stated. In the event of violation of any
statistical assumption, alternative analytic methods (e.g.,
non-parametric statistics) were used. Mean imputation was
used for all questionnaires where only one item was
missing. Missing values were not replaced from question-
naires where more than one item was missing.
Tests of Group Equivalence
Comparisons on a range of clinical variables were con-
ducted between those individuals with a specific phobia of
vomiting recruited from the Internet and those who were
seen face-to-face in a clinical setting. These two emeto-
phobia subgroups did not differ on total SPOVI score
(t = 1.14, df = 93, p = .26), total EmetQ-13 score
(t = 0.82, df = 89, p = .42), total DS-R score (t = 0.35,
df = 87, p = .73), total OCI score (t = 0.37, df = 80,
p = .71), PHQ-9 score (t = 0.17, df = 83, p = .86),
GAD-7 score (t = 1.42, df = 87, p = .16), or WSAS score
(t = 0.37, df = 83, p = .71). The group seen in a clinical
setting reported a significantly higher HAI total score
(M = 22.76, SD = 8.36) than the group recruited from the
Internet (M = 18.64, SD = 7.64, t = 2.05, df = 74,
p = .044). As only one scale differed between the two
groups, it was decided that the specific phobia of vomiting
group could be treated as a single cohort.
Factor Structure
There was insufficient variance in the non-emetophobic
group to permit meaningful factor analysis, and so factor
analysis was conducted with the emetophobic group only.
Horn’s parallel factor analysis (Horn 1965) was used to
examine the factor structure of the SPOVI. This was
computed using FACTOR version 8.02 (Lorenzo-Seva and
Ferrando 2006). This method was chosen as it is more
accurate than other methods in determining the number of
components/factors to extract during factor analysis (Wil-
son and Cooper 2008; Zwick and Velicer 1986). Factors
were extracted using a principal components extraction
method, with this being followed by promax rotation,
permitting correlation between the emergent factors.
Bartlett’s statistic (714.3, df = 91, p \ .001) and the Kai-
ser–Meyer–Olkin test (KMO = .874) indicated that the
sample was adequate for factor analysis. The factor anal-
ysis in the emetophobia group suggested 2 latent factors,
which together accounted for 58.67 % of the overall item
variance. Table 2 shows the loadings of the items on each
of the two emergent factors. All items demonstrated ade-
quate communality, and returned factor loadings of [ .40
on only one factor (see Table 2). The first factor repre-
sented avoidance behavior and the second factor repre-
sented threat monitoring and control of symptoms. The
Avoidance factor comprised a wide range of avoidance
behaviors including avoiding or trying to control people,
objects, situations, certain food, thoughts and images
because of the fear of vomiting. The threat monitoring
factor included processes such as worrying about vomiting;
mental planning how to stop oneself from vomiting;
attempting to find reasons for nausea; and being exces-
sively self-focussed on monitoring the feeling of being ill.
When subscales were created from the items using the
factor structure in Table 2, the internal consistency
(Cronbach’s a) in the emetophobic sample was .85 and .88
for the first and second subscales, respectively.
Internal Consistency
The Cronbach’s alpha of the SPOVI for the emetophobia
group was .91. In the community group, Cronbach’s alpha
was calculated as .81.
Cogn Ther Res (2013) 37:595–604 599
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Test–Retest Reliability
Test–retest reliability was calculated by examining the cor-
relation between scores from two administrations of the
SPOVI occurring one week apart, in a subsample of 31
individuals from the emotophobia group who were not cur-
rently undergoing treatment for their phobia of vomiting. A
one-week hiatus period was chosen as this would be con-
sistent with the use of the SPOVI in weekly therapy sessions
as a measure of treatment effect. The SPOVI showed good
one-week stability (r = .85, p \ .001), and showed no
significant change between the two administrations
(MTime1 = 29.52, SDTime1 = 14.60, MTime2 = 30.39,
SDTime2 = 13.57, t = 0.62, df = 30, p = .54).
Group Differences
SPOVI scores were significantly higher in the emetophobia
group (M = 30.62, SD = 12.95) compared with the com-
munity controls (M = 1.53, SD = 3.49, t = 20.61,
df = 183, p \ .001). Table 3 provides the mean and stan-
dard deviation for all the scales in the emetophobia and
community group.
We used the total SPOVI score in an analysis of the sen-
sitivity and specificity of the measure in determining diag-
nostic status, as well as a receiver operating curve (ROC)
analysis. Receiver Operating Characteristics (ROC) analysis
was used to illustrate graphically the sensitivity and speci-
ficity of the SPOVI in discriminating between patients with
emetophobia and the control group at different cut-off val-
ues. The area under the curve (AUC) for this analysis was
.994 (p \ .001) indicating that the SPOVI is a very accurate
diagnostic test. To determine the optimal cut-off value of the
SPOVI for the identification of subjects with emetophobia,
sensitivity and specificity were computed for different cut-
off scores. A range of cut-off scores is presented in Table 4,
along with the sensitivity and specificity in identifying
individuals with specific phobia of vomiting (as distinct from
the control group). We suggest a cut-off score of [ 10 as the
best compromise between sensitivity and specificity in
detecting the presence of emetophobia.
Concurrent Validity
Across the whole sample, the concurrent validity against
EmetQ-13 was high (r = .82, p \ .001), indicating that the
two measures are assessing similar constructs.
Table 2 Factor loadings and communality of SPOVI items
Item Factor
I
Factor
II
Communality
I have been avoiding adults or
children because of my fear of
vomiting
.94 -.19 .73
I have been avoiding objects that
other people have touched
because of my fear of vomiting
.83 -.12 .59
I have been avoiding situations or
activities because of my fear of
vomiting
.81 -.02 .64
I have been looking at others to
see if they may be ill and
vomiting
.72 -.01 .51
I have escaped from situations
because I am afraid I or others
may vomit
.58 .19 .49
I have been restricting the amount
or type of foot I eat or alcohol I
drink because of my fear of
vomiting
.46 .25 .40
I have been trying to avoid or
control any thoughts or images
about vomiting
.45 .38 .53
I have been feeling nauseous -.27 1.00 .80
If I think I am going to vomit, I do
something to try to stop myself
from vomiting
-.16 .87 .64
I have been trying to find reasons
to explain why I feel nauseous
-.04 .80 .62
I have been focussed on whether I
feel ill and may vomit, rather
than on my surroundings
.12 .68 .57
I have been worrying about
myself or others vomiting
.23 .60 .56
I have been thinking about how to
stop myself or others from
vomiting
.31 .55 .57
I have been seeking reassurance
that I or others will not be ill and
vomit
.32 .53 .57
Loadings [.40 are displayed in bold
Table 3 Age and scores for the clinical cohorts and community
controls
Emetophobia
group
Community
control group
Comparison
& effect size
M SD M SD
Age 32.6 12.1 32.5 11.0 t = 0.1, d = 0.01
SPOVI 30.6 12.9 1.5 3.5 t = 20.6**, d = 3.55
DS-R 57.7 14.4 49.5 17.2 t = 3.4**, d = 0.52
OCI 33.4 25.6 15.1 23.2 t = 4.6**, d = 0.75
HAI 19.8 8.0 7.7 5.1 t = 11.3**, d = 1.85
EmetQ-13 37.3 8.9 10.6 7.6 t = 21.2**, d = 3.24
PHQ-9 9.8 7.8 4.4 6.5 t = 4.9**, d = 0.76
GAD-7 9.4 6.5 3.4 5.6 t = 6.5**, d = 0.99
WSAS 17.3 8.3
** p \ .001
600 Cogn Ther Res (2013) 37:595–604
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Convergent Validity
In the combined sample, the SPOVI was moderately cor-
related with the Disgust Scale Revised (r = .36, p \ .001),
indicating that high levels of symptoms of emetophobia
were associated with higher disgust sensitivity. The SPOVI
correlated moderately with the OCI total score (r = 0.49,
p \ .001) and highly with the Health Anxiety Inventory
(r = .78, p \ .001), indicating a strong relationship
between fears of vomiting and especially health anxiety.
There was also a high correlation with the GAD-7 scale
(r = .59, p \ .001), and moderate correlation with the
PHQ-9 (r = .49, p \ .001) showing that higher scores on
the SPOVI are associated with greater symptoms of gen-
eralized anxiety and depression. The SPOVI also correlated
moderately with the Work and Social Adjustment Scale
(r = .52, p \ .001). Each of the subscales (avoidance and
threat monitoring) followed a similar pattern of correlation
to each of the scales as the total SPOVI score (see Table 5).
Sensitivity to Treatment Effect
The eight participants in the emetophobia group who were
treated for their phobia had a mean age of 30.2 and stan-
dard deviation of 14.4. SPOVI scores were tracked during
treatment in eight participants in order to determine sen-
sitivity to change (Fig. 1).
Figure 2 shows change on the SPOVI for the 8 partici-
pants receiving Cognitive Behavior Therapy. Non-para-
metric comparisons (Wilcoxin signed ranks tests) were
used between pre-treatment and post-treatment scores due
to the small sample size. Mean SPOVI scores reduced
significantly during treatment (Z = 2.52, p = .012). The
mean score reduced from 37.4 (standard deviation 14.1) to
post treatment score at 14.4 (standard deviation 12.5). The
PHQ-9 measure of depression also reduced during treat-
ment (Z = 2.21, p = .027), as did the GAD-7 measure of
generalized anxiety symptoms (Z = 2.38, p = .018).
Discussion
The current study examined the psychometric properties of
a novel self-report measure of the symptoms of emeto-
phobia. Analysis of SPOVI results in clinical and norma-
tive samples established the inventory’s reliability,
validity, and factor structure.
Table 4 Sensitivity and specificity of SPOVI cutoff scores
SPOVI cutoff score Sensitivity Specificity
[5 1.00 .92
[10 .97 .96
[15 .84 .98
[20 .75 1.00
[25 .65 1.00
Table 5 Convergent validity of the SPOVI subscales
Factor I
avoidance
Factor II
threat monitoring
DS-R .35 .34
OCI .51 .44
GAD-7 .46 .49
PHQ-9 .56 .60
WSAS .51 .44
HAI .76 .76
All correlations significant at p \ .01
Fig. 1 Receiver operating curve for SPOVI total score
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Fig. 2 Change in SPOVI total scores for eight participants undergo-
ing treatment
Cogn Ther Res (2013) 37:595–604 601
123
Author's personal copy
The two assessments of reliability of the SPOVI were
measures of internal consistency and test–retest stability.
The SPOVI demonstrated good internal consistency,
demonstrating that the scale was measuring a coherent
single construct. The SPOVI was also shown to have
adequate temporal stability as measured over a 1 week
test–retest period.
Evidence for the validity of the SPOVI in measuring
symptoms of emetophobia came from correlations with
another measure of emetophobia and emetophobic-related
constructs, theory-consistent group differences, and sensi-
tivity to the effects of treatment on symptom change. The
SPOVI showed significant and moderate-to-strong corre-
lations with measurements of health anxiety and OCD
symptoms, as well as measures of GAD and depression
symptoms. Higher SPOVI scores were also associated with
reductions in work and social adjustment. Importantly, the
SPOVI correlated strongly with another self-report mea-
sure of emetophobic symptoms. Total SPOVI scores were
significantly higher in individuals with emetophobia com-
pared to a non-clinical normative sample. Individuals
treated for emetophobia showed significant reductions in
SPOVI scores over the course of their intervention.
There were two factors identified which we have
labelled ‘‘avoidance’’ and ‘‘threat monitoring’’ and may be
used as subscales. They are theoretically meaningful and
consistent with phenomenology of emetophobia. All spe-
cific phobias are characterized by avoidance of cues that
may lead to activation of fear and disgust related to the
phobia. Threat monitoring and mental planning interacts
with avoidance. Thus when avoidance behaviour increases
then the process of threat monitoring and vigilance
decreases. When approach behaviour increases then the
threat monitoring and vigilance increase.
The only other measurement tool for emetophobia, the
EmetQ-13, was developed independently from the SPOVI,
and covers a different range of symptoms. The factor
structure of the EmetQ-13, however, also shows a separa-
tion of avoidance symptoms from other symptoms,
although for the EmetQ-13, these avoidance symptoms are
separated into two distinct factors: avoidance of situations
and movement, and avoidance of people who may vomit.
The EmetQ also includes a third factor on misinterpretation
of seeing or smelling vomit in anticipation of oneself
vomiting. This factor does not occur on the SPOVI.
However the advantage of the SPOVI is the measurement
of the processes of the threat monitoring and mental
planning which does not occur on the EmetQ-13. Both
scales are brief and may be used concurrently.
The immediate implication from the current work is that
the SPOVI now exists as a potential measure for use in the
assessment and quantification of severity of symptoms of
emetophobia. Such a measure can be used for clinical
purposes such as the assessment of initial severity of symp-
toms, to measure changes in symptom severity over the
course of therapy and to identify specific behaviours and
processes to target in therapy. It may be also of interest to
know whether the factor of avoidance or threat monitoring
changes first or which of the two factors leads to greater
change in treatment. In research settings, the SPOVI may
also be used to assess the impact of treatments for emeto-
phobia in case studies, and in larger controlled and uncon-
trolled trials with larger samples. The SPOVI is brief, and so
can be used weekly to assess symptoms and symptom change
in both clinical and research settings.
The scale may assist in identifying people in the com-
munity with emetophobia to obtain better data on preva-
lence. The prevalence of emetophobia may be uncommon
but researchers and people with emetophobia need a scale
to use in future controlled trials and to estimate effect size
of different treatments and audit outcome.
More broadly, our results provide interesting information
about the association of emetophobia symptoms with the
symptoms of other related conditions. Individuals with fears
of vomiting were also more likely to report higher levels of
disgust sensitivity, confirming the finding of van Overveld
et al. (2008). Symptoms of emetophobia were most strongly
associated with symptoms of health anxiety, which reflect
the overlapping concern with developing a physical illness
(Salkovskis et al. 2002). As a group the mean score on the
HAI crosses the suggested cut off score for hypochondriacal
disorder (Salkovskis et al. 2002). This finding was not
unexpected as people with emetophobia are frequently
fearful of becoming ‘‘ill’’ because of the fear that it might
lead to vomiting. The SPOVI also correlated moderately
with the OCI suggesting some overlap with the compulsive
behaviours (e.g. washing and ruminating) as a means of
trying to prevent vomiting. The SPOVI also correlated
strongly with symptoms of depression and general anxiety.
Depression is probably a consequence of the chronicity and
handicap caused by emetophobia over many years and would
be expected to be correlated with the SPOVI. The correlation
of general anxiety and SPOVI scales may occur from a
shared construct such as anxiety sensitivity. In addition
people with emetophobia may be in a constant of anticipa-
tory anxiety waiting for their self or others to vomit without
any warning.
There were no significant differences between the
emetophobia participants recruited in a clinical setting and
the Internet, apart from slightly higher health anxiety in the
clinical setting. This suggests that there may be factors not
measured in the current study that determine treatment
seeking such as readiness to change or the confidence in
treatment offered. Some of those recruited over the Internet
had experienced failed treatments in the past, which is
likely to influence any decision on further treatment.
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The current study has a number of strengths and new
contributions to the scientific literature on emetophobia.
The study utilised a sample of 95 individuals with a
DSMIV diagnosis of a specific phobia of vomiting. This is
among the largest samples of individuals with emetophobia
utilised in previous research, and increases our confidence
that the findings are likely to be representative of the
population of individuals with the condition. Comparison
with a normative sample allowed for inferences to be made
regarding the clinical nature of emetophobic symptoms.
There were limitations in the current research that
should be considered when interpreting our results. A
significant limitation of the results is the small sample used
to assess the sensitivity of the SPOVI to the effect of
treatment. Despite its small size, the sample was still suf-
ficient to detect significant differences and give us confi-
dence to use the SPOVI in treatment trials.
The use of a combined clinical group, including indi-
viduals diagnosed using a telephone interview, may also
reduce certainty in the homogeneity and diagnostic cer-
tainty of the clinical group.
Additionally, although our cohorts had a male–female
imbalance, this is similar to previous research that has
found that the majority of individuals with emetophobia are
women (Veale and Lambrou 2006; Lipsitz et al. 2001).
This imbalance does, however, mean that our results may
not be representative of the rarer cases of male emeto-
phobia, few of which were assessed in our method. Despite
these limitations, we present these results as an initial
investigation that may be replicated in future research.
Future studies might administer the scale to a population
who regularly experience nausea as a symptom of another
anxiety disorder in order to determine whether the scale
discriminates between those with Specific Phobia of
Vomiting as opposed to those who experience nausea and
have another anxiety disorder or who might have some fear
of vomiting without reaching the criterion for a specific
phobia. A further limitation is that the scale has not yet
been compared to a construct that was theoretically distinct
to determine divergent validity.
This study represents the first initial psychometric val-
idation of the SPOVI. Replication of our results in a new
sample of individuals with emetophobia would add
strength to our findings, particularly the latent structure of
the symptoms found in our sample. Confirmatory factor
analytic procedures would allow for an overall assessment
of ‘model fit’ of our factor structure within a different
sample. Such procedures have been used previously to
assess the generalisability of a previously derived latent
structure in a new sample (e.g., Boschen and Oei 2006).
Future research with the SPOVI will need to examine
the sensitivity of the measure to treatment effects in a
larger sample in a controlled trial, as well as the ability of
the measure to distinguish between responders and non-
responders. As discussed above, the SPOVI may be used as
an assessment of current symptom status and change in
these symptoms over time for audit of outcome in national
datasets (Clark et al. 2009). The SPOVI and EmetQ may be
downloaded from www.kcl.ac.uk/cadat/ under ‘‘Research’’,
‘‘Questionnaires’’.
Conclusion
The current study has validated a brief self-report scale that
can be used by clinicians and researchers to assess the
symptoms of individuals with a specific phobia of vomit-
ing. There are two subscales of avoidance and threat
monitoring. The SPOVI can be used as a tool for treatment
planning and outcome measurement and consists of two
subscales.
Conflict of interest None.
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